## Abstract We have recently described a cell type‐specific surface (SF) antigen that is deleted in chick fibroblasts transformed by Rous sarcoma virus. SF antigen is a major surface component and makes up about 0.5% of the total protein on normal cultured fibroblasts. The antigen is shed from norm
Flavonoids alter P-gp expression in intestinal epithelial cells in vitro and in vivo
✍ Scribed by Katrin Lohner; Kerstin Schnäbele; Hannelore Daniel; Doris Oesterle; Gerhard Rechkemmer; Martin Göttlicher; Uwe Wenzel
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 733 KB
- Volume
- 51
- Category
- Article
- ISSN
- 1613-4125
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Flavonoids are secondary plant metabolites included in our diet but are also provided in a growing number of supplements. They are suggested to interact with intestinal transport systems including phospho‐glycoprotein (P‐gp) which mediates the efflux of a variety of xenobiotics back into the gut lumen. In human intestinal Caco‐2 cells, we tested the effects of 14 different flavonoids on P‐gp expression in vitro. Protein expression levels were quantified by Western blotting, flow cytometry, and real‐time PCR. Except apigenin, all flavonoids at concentrations of 10 μM increased P‐gp expression in Western blotting experiments when cells were exposed to the compounds over 4 wk. Flavone was one of the most effective P‐gp inducers in Caco‐2 cells and its effects were, therefore, also assessed for changes in P‐gp in vivo in the gastrointestinal tract of C57BL/6 mice. P‐gp expression was significantly increased by flavone (400 mg/kg body weight×day over 4 wk) in the small intestine but not in the colon which displayed intrinsically the highest expression level. In conclusion, the increase in P‐gp expression caused by flavonoids in intestinal epithelial cells in vitro and also in vivo may serve as an adaptation and defense mechanism limiting the entry of lipophilic xenobiotics into the organism.
📜 SIMILAR VOLUMES
The intestinal efflux pump, P-glycoprotein (P-gp), located in the apical membranes of intestinal absorptive cells, can reduce the bioavailability of a wide range of drugs which are substrates for this membrane transporter. In addition to anticancer and anti-HIV drugs, NCEs for other disease indicati
## Abstract Inflammatory bowel diseases (IBD) are linked to an increased risk of developing colon cancer, by inflammatory mediators and alterations to the extracellular matrix (ECM). The events induced by inflammatory mediators lead to dysregulated activation and induction of inflammatory genes suc
## Abstract ## Objective To evaluate the effect of duloxetine (DLX) on the P‐glycoprotein (P‐gp) function __in vitro__ and __in vivo__. ## Method __In vitro__ experiment was conducted using the Caco‐2 cell, a human colon cancer cell line that naturally expresses the P‐gp and P‐gp function was ev
The purpose of this study was to investigate the in vitro and in vivo interactions between flavonoids and P-glycoprotein (P-gp) substrates. The inhibitory effects of flavonoids on P-gp were determined by accumulation studies in P-gp-overexpressing MCF-7/ADR cells using daunomycin (DNM) as a model su